Adverse Events Seen With JAK Inhibitors for Myelofibrosis

Opinion
Video

The JAK inhibitors approved for myelofibrosis have common side effects of cytopenias and gastrointestinal issues, with additional risks of weight gain and cardiac effects and diarrhea; momelotinib and pacritinib show improved tolerability compared to earlier JAK inhibitors.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Headshot of a woman with shoulder-length brown hair wearing a black blazer with a maroon top
Related Content
Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
August 28th 2025
Article
Oncology Nurses Provide Patients an Avenue to Supportive Care

Oncology Nurses Provide Patients an Avenue to Supportive Care

Diana Martins-Welch, MD
August 28th 2025
Article
New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

Daniel J. George, MD
August 28th 2025
Article
Adverse Events of CAR T-Cell Therapy

Adverse Events of CAR T-Cell Therapy

Sattva S. Neelapu, MD
August 28th 2025
Article
Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

MaryBeth Freeman, MPH
August 28th 2025
Article
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

Hyman B. Muss, MD
August 28th 2025
Article